Jennifer Jaehie Choi, MD
Neurology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Choi’s office at (408) 972-3000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A147487 · Current
Licensed to practise in California · since 2017 · expires 2028-07-31 · Northwestern University Feinberg School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$244,769
Pharmacies billed $244,769 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (14 of 988) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
928 generic and fewer than 11 brand-name prescriptions · $244,769 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ingrezza | None | 12 | $108,179 | $9,015 |
| Rytary | Parkinson's | 18 | $35,862 | $1,992 |
| Carbidopa-Levodopa | None | 357 | $25,978 | $73 |
| Carbidopa-Levodopa Er | None | 88 | $4,689 | $53 |
| Entacapone | None | 41 | $4,588 | $112 |
See all 19 drugs
| Ingrezza | None | 12 | $108,179 | $9,015 |
| Rytary | Parkinson's | 18 | $35,862 | $1,992 |
| Carbidopa-Levodopa | None | 357 | $25,978 | $73 |
| Carbidopa-Levodopa Er | None | 88 | $4,689 | $53 |
| Entacapone | None | 41 | $4,588 | $112 |
| Carbidopa | None | 18 | $3,350 | $186 |
| Levetiracetam | None | 45 | $2,605 | $58 |
| Gabapentin | None | 53 | $2,226 | $42 |
| Propranolol | None | 19 | $1,626 | $86 |
| Primidone | None | 26 | $1,528 | $59 |
| Glycopyrrolate | None | 34 | $846 | $25 |
| Amantadine | None | 18 | $613 | $34 |
| Lamotrigine | None | 21 | $502 | $24 |
| Divalproex | None | 14 | $413 | $29 |
| Donepezil | None | 14 | $402 | $29 |
| Ropinirole | None | 14 | $274 | $20 |
| Pramipexole Dihydrochloride | None | 13 | $272 | $21 |
| Asa-Butalb-Caffeine-Codeine | None | 13 | $259 | $20 |
| Clonazepam | None | 16 | $111 | $7 |
Year by year
| 2024 | 988 | 278 | 1% (14) | None | $244,769 |
| 2023 | 661 | 191 | None | None | $213,353 |
| 2022 | 803 | 225 | None | None | $305,085 |
| 2021 | 505 | 157 | None | None | $59,916 |
| 2020 | 391 | 106 | None | 10% | $43,473 |
| 2019 | 358 | 115 | None | 21% | $84,204 |
| 2018 | 504 | 106 | None | 24% | $118,119 |
| 2017 | 108 | 42 | 0% (0) | 20% | $20,358 |
| 2016 | 70 | 16 | 0% (0) | 27% | $32,388 |
| 2015 | 42 | 12 | 0% (0) | None | $3,484 |
| 2014 | 50 | 13 | 0% (0) | None | $3,496 |
| 2013 | 40 | None | None | 30% | $2,425 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Rytary | Parkinson's | 14 | $38,501 | $2,750 |
| Carbidopa-Levodopa | None | 271 | $23,476 | $87 |
| Carbidopa-Levodopa Er | None | 78 | $4,785 | $61 |
| Entacapone | None | 17 | $1,561 | $92 |
| Primidone | None | 25 | $1,501 | $60 |
| Levetiracetam | None | 17 | $834 | $49 |
| Oxcarbazepine | None | 15 | $816 | $54 |
| Gabapentin | None | 14 | $612 | $44 |
| Lamotrigine | None | 17 | $542 | $32 |
| Pramipexole Dihydrochloride | None | 12 | $262 | $22 |
| Ropinirole | None | 11 | $180 | $16 |
| Sertraline | None | 11 | $105 | $10 |
| Clonazepam | None | 11 | $76 | $7 |
2022: 19 drugs
| Austedo | None | 11 | $202,819 | $18,438 |
| Carbidopa-Levodopa | None | 303 | $27,395 | $90 |
| Rytary | Parkinson's | 19 | $21,006 | $1,106 |
| Ubrelvy | None | 13 | $7,406 | $570 |
| Ajovy | None | 12 | $5,659 | $472 |
| Carbidopa-Levodopa Er | None | 84 | $4,419 | $53 |
| Entacapone | None | 11 | $2,505 | $228 |
| Carbamazepine Er | None | 13 | $2,082 | $160 |
| Primidone | None | 29 | $1,964 | $68 |
| Levetiracetam | None | 19 | $1,176 | $62 |
| Lamotrigine | None | 19 | $675 | $36 |
| Phenytoin Sodium Extended | None | 13 | $649 | $50 |
| Glycopyrrolate | None | 13 | $581 | $45 |
| Gabapentin | None | 25 | $568 | $23 |
| Divalproex | None | 14 | $415 | $30 |
| Topiramate | None | 15 | $320 | $21 |
| Sertraline | None | 23 | $252 | $11 |
| Pramipexole Dihydrochloride | None | 13 | $197 | $15 |
| Clonazepam | None | 11 | $110 | $10 |
2021: 10 drugs
| Rytary | Parkinson's | 15 | $19,398 | $1,293 |
| Carbidopa-Levodopa | None | 185 | $16,547 | $89 |
| Carbidopa-Levodopa Er | None | 45 | $2,014 | $45 |
| Levetiracetam | None | 16 | $1,523 | $95 |
| Gabapentin | None | 24 | $739 | $31 |
| Phenytoin Sodium Extended | None | 11 | $662 | $60 |
| Primidone | None | 13 | $580 | $45 |
| Lamotrigine | None | 13 | $304 | $23 |
| Sertraline | None | 18 | $257 | $14 |
| Pramipexole Dihydrochloride | None | 12 | $179 | $15 |
2020: 7 drugs
| Rytary | Parkinson's | 21 | $18,410 | $877 |
| Carbidopa-Levodopa | None | 150 | $12,115 | $81 |
| Carbamazepine Er | None | 14 | $3,271 | $234 |
| Carbidopa-Levodopa Er | None | 37 | $1,981 | $54 |
| Trospium Chloride | None | 12 | $860 | $72 |
| Gabapentin | None | 25 | $813 | $33 |
| Pramipexole Dihydrochloride | None | 19 | $273 | $14 |
2019: 9 drugs
| Rytary | Parkinson's | 34 | $49,979 | $1,470 |
| Myrbetriq | None | 19 | $8,657 | $456 |
| Carbidopa-Levodopa | None | 84 | $5,109 | $61 |
| Carbidopa-Levodopa Er | None | 29 | $2,597 | $90 |
| Amantadine | None | 15 | $662 | $44 |
| Duloxetine | None | 17 | $521 | $31 |
| Donepezil | None | 15 | $240 | $16 |
| Gabapentin | None | 15 | $195 | $13 |
| Clonazepam | None | 18 | $100 | $6 |
2018: 14 drugs
| Rytary | Parkinson's | 55 | $49,408 | $898 |
| Myrbetriq | None | 18 | $14,285 | $794 |
| Carbidopa | None | 15 | $12,732 | $849 |
| Carbidopa-Levodopa | None | 68 | $4,375 | $64 |
| Carbidopa-Levodopa Er | None | 41 | $3,340 | $81 |
| Duloxetine | None | 32 | $3,288 | $103 |
| Amantadine | None | 22 | $1,863 | $85 |
| Quetiapine | None | 28 | $1,421 | $51 |
| Trospium Chloride | None | 14 | $1,294 | $92 |
| Galantamine Hbr | None | 11 | $786 | $71 |
| Gabapentin | None | 25 | $428 | $17 |
| Donepezil | None | 32 | $222 | $7 |
| Clonazepam | None | 30 | $158 | $5 |
| Meloxicam | None | 12 | $80 | $7 |
2017: 3 drugs
| Rytary | Parkinson's | 14 | $8,791 | $628 |
| Carbidopa-Levodopa Er | None | 13 | $859 | $66 |
| Carbidopa-Levodopa | None | 11 | $453 | $41 |
2016: 1 drug
| Carbidopa-Levodopa Er | 17 | $653 | $38 |
Money from drug and device companies
$125 in 2023
| 2023 | 1 | 1 | None | $125 |
| 2019 | 3 | 4 | None | $422 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AbbVie | Qulipta | $125 | 1 payment
|
See the published payment
| AbbVie | Meals · 2023-02-08 | Qulipta | $125 |
See earlier years (2019)
2019: $422
| Boston Scientific | Spectra Wavewriter | $223 | 1 payment
|
| Medtronic USA | Activa | $184 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $15 | 1 payment
|
Professional record
- NPI
- 1386987709
- Licence
- CA A147487California A147487: Current · expires 2028-07-31
- Trained
- Northwestern University Feinberg Medical School, 2013
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 275 Hospital Pkwy Ste 800, San Jose, CA, 95119
- NPI first listed
- 2013-04-03
- NPI last updated
- 2021-12-17
- NPI record certified
- 2020-06-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1635 Divisadero St Ste 515, San Francisco, CA, 94115
This office lists an electronic records connection.